AIDS Vaccine
The purpose of this toolkit is to assist Canadian organizations working with international partners to effectively engage in their work. An evaluation report of the NPT communications project has already been prepared; this toolkit focuses primarily on the partnership model rather than the content of the workshops.
Research and clinical trials of new HIV prevention technologies, such as vaccines, microbicides and pre-exposure prophylaxis, provide hope for more effective prevention of HIV transmission. Communities are aware of research developments and need timely, accurate information which they can use to inform and engage their members. In response to this need, the Canadian AIDS Society, the Canadian AIDS Treatment Information Exchange and the Interagency Coalition on AIDS and Development, in partnership with the Coalition des organismes Québécois de lutte contre le sida, hosted a one-day meeting in Montreal on March 4, 2010 with 74 registered participants from a variety of communities. International and Canadian presenters provided updates on research, ethics … Read more
There are a number of global efforts underway to develop new technologies to prevent HIV. Currently, there is research being conducted on vaginal and rectal microbicides, vaccines, pre‐exposure prophylaxis (PrEP) and HIV treatment as prevention. This fact sheet provides a brief definition of each of the potential prevention tools being researched, and gives an overview of the current state of research. The fact sheet then provides an overview of the prevention technologies that we currently have at our disposal―female and male condoms, and medical male circumcision―and summarizes recent findings about these technologies. The fact sheet then outlines research into prevention technologies that have had unsuccessful results―diaphragms and cervical barriers, and … Read more
The development of a safe and effective AIDS vaccine is the primary goal of AIDS vaccine research and, once achieved, will have a remarkable impact on reducing the spread of HIV. But there are other added benefits. Conducting AIDS vaccine research in developing countries also strengthens their health systems by reinforcing their research capacity and contributing to health system functioning more broadly. This fact sheet examines the impact of AIDS vaccine research on health systems strengthening in five key areas: the training and retention of human resources; infrastructure development; institutional development; improved health services; and enhanced HIV services.